number_new,number,nct_id,pruefer_original,pruefer_DC,cities_lead,cities_lead_corrected,manual_validation_cities_lead,Publication identified in which step,publication_DOI,publication_URL,article_yes_no,publication_date,unsure_about_publ_yes_no,reason,other_comments,brief_title,official_title,study_first_submitted_date,start_date,start_date_type,completion_date,completion_date_type,PI_name,PI_affiliation,interventions,overall_status,phase,enrollment,enrollment_type,were_results_reported
381,441,NCT01510080,TB,HK,Frankfurt,Frankfurt,Frankfurt,3,10.1002/cpp.1968,https://onlinelibrary.wiley.com/doi/abs/10.1002/cpp.1968,yes,05.10.2016,no,,,Acceptance and Efficacy of Live Supervision,Live Supervision Put to Test - Studies of Acceptance and Efficacy of Computer-assisted Live Supervision,2011-12-12,2012-01-31,NA,2014-08-31,Actual,"Florian Weck, PhD",Goethe University,Computer-assisted live supervision | Delayed video-based supervision,Completed,N/A,42,Actual,FALSE
399,511,NCT02990039,TB,HK,Greifswald,Greifswald,Greifswald,1,10.1186/s12872-020-01551-9 ,https://pubmed.ncbi.nlm.nih.gov/32503441/,yes,05.06.2020,no,,,A Tailored Feasibility Study to Increase Physical Activity and to Reduce Sedentary Time,A Tailored Feasibility Study to Increase Physical Activity and to Reduce Sedentary Time,2016-11-15,2015-02-28,NA,2016-09-30,Actual,"Sabina Ulbricht, Dr.","Institute of Social Medicine and Prevention, University Medicine Greifswald, Greifswald, Germany",Counseling letter,Completed,N/A,176,Actual,FALSE
1190,535,NCT01272557,TB,HK,Halle,Halle,Halle,8,,https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1559262,,,,,,Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial,Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial,2011-01-06,2010-12-31,NA,2014-12-31,Anticipated,NA,NA,Doxorubicin | Sorafenib,Unknown status,Phase 2,170,Anticipated,FALSE
410,563,NCT02283099,TB,HK,Hamburg,Hamburg,Hamburg,3,10.1093/infdis/jiy565 ,https://pubmed.ncbi.nlm.nih.gov/30452666/,yes,29.01.2019,no,,,"Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)","An Open Label, Single Center, Dose Escalation Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Single Ascending Dose of the Ebola Virus Vaccine rVSVΔG-ZEBOV-GP (BPSC1001)",2014-10-31,2014-11-30,NA,2015-11-30,Actual,"Marylyn M. Addo, MD",Universitätsklinikum Hamburg-Eppendorf,rVSVΔ-ZEBOV-GP,Completed,Phase 1,30,Actual,FALSE
10,780,NCT01351246,SW,HK,Köln,Köln,Köln,3,10.1177/1087054718810797,https://journals.sagepub.com/doi/abs/10.1177/1087054718810797,yes,17.11.2018,no,,,Guided Self-Help for Parents of Children With Attention-Deficit/Hyperactivity Disorder (ADHD),Guided Self-Help for Parents of Children With Attention-Deficit/Hyperactivity Disorder (ADHD): A Feasibility and Effectiveness Study,2011-05-02,2010-05-31,NA,2014-03-31,Actual,"Manfred Döpfner, PhD",University of Cologne,CBT Based Self-help Workbook + Counseling Telephone,Completed,N/A,300,Actual,FALSE
45,905,NCT02848352,SW,HK,Marburg,Marburg,Marburg,3,10.1016/j.jad.2020.05.056,https://www.sciencedirect.com/science/article/abs/pii/S0165032720302500,yes,23.05.2020,no,,,The Role of Expectations in Experimentally Induced Sadness,The Role of Expectations in Experimentally Induced Sadness,2016-06-29,2016-06-30,NA,2016-10-31,Actual,"Winfried Rief, Professor",Philipps University Marburg Medical Center,Placebo nasal spray | Film Sequence,Completed,N/A,128,Actual,FALSE
181,1015,NCT01352702,NR,HK,Munich,TU,Munich,3,10.1155/2015/798486 ,https://pubmed.ncbi.nlm.nih.gov/26229963/,yes,01.07.2015,,,,Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation,Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation,2011-05-11,2011-05-31,NA,2014-05-31,Actual,"Julinda Mehilli, MD","Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen",Dabigatran | Phenprocoumon,Terminated,Phase 4,46,Actual,FALSE
182,1017,NCT01266837,NR,HK,Munich,LMU,Munich Berlin Dresden Erlangen Essen Hannover Homburg Jena Nürnberg,3,,https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.33349,yes,18.10.2020,no,,,"Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)","An Open Label, Single Arm Trial to Characterize Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus After Failure of the First VEGF-targeted Therapy",2010-12-23,2011-03-31,NA,2017-10-31,Actual,"Michael Staehler, Dr. med","Ludwig-Maximilians-University Munich, Hospital Grosshadern",Everolimus,Completed,Phase 4,64,Actual,FALSE
183,1018,NCT01258153,NR,HK,Munich,LMU,Munich,3,10.1016/S0016-5085(15)31431-1,https://www.gastrojournal.org/article/S0016-5085(15)31431-1/pdf,yes,01.04.2015,yes,"no abstract or full text  available, my judgement is only based on the title (perfect match)",,Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic,"Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Oral Administration of Nepadutant in Infant Colic",2010-12-09,2010-11-30,NA,2014-03-31,Actual,"Sibylle Koletzko, MD","Dr. v. Haunersches Kinderspital Ludwig Maximilians University D- 80337 München, Germany",Placebo matching Nepadutant oral solution | Nepadutant oral solution | Nepadutant oral solution,Completed,Phase 2,115,Actual,TRUE
58,1082,NCT02207582,SW,HK,Regensburg,Regensburg,Regensburg,2,10.1016/j.jpsychires.2020.10.011,https://www.sciencedirect.com/science/article/pii/S0022395620310141,yes,16.10.2020,no,,,Prefrontal Transcranial Random Noise Stimulation in Patients With Depression,Prefrontal Transcranial Random Noise Stimulation in Patients With Depression,2014-07-31,2014-07-31,NA,2016-12-06,Actual,Berthold Langguth,University of Regensburg,Verum Prefrontal tRNS | Placebo Prefrontal tRNS,Terminated,N/A,44,Actual,FALSE
119,1168,NCT03039387,MH,HK,Tübingen,Tübingen,Tübingen,3,,https://www.nature.com/articles/s41598-019-43234-2,no,01.05.2019,no,Publication could be based on the same study however no prim. Outcomes reported. Also only 22/44 patient data reported.,,Effects of tDCS on Cognitive Control and Emotion Regulation in Depressed Patients,The Effect of Transcranial Direct Current Stimulation (tDCS) on Cognitive Control and Emotion Regulation in Depressed Patients,2016-10-28,2016-09-30,NA,2017-04-30,Anticipated,NA,NA,anodal transcranial direct current stimulation | transcranial direct current stimulation (sham),Unknown status,N/A,44,Anticipated,FALSE
132,1206,NCT02076646,MH,HK,Tübingen,Tübingen,Tübingen,3,10.1007/s00262-019-02383-z,https://link.springer.com/article/10.1007/s00262-019-02383-z#citeas,yes,03.09.2019,no,,,A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma,A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma,2014-02-24,2013-10-31,NA,2017-06-30,Anticipated,"Claus Garbe, Prof. M.D.",University Hospital Tuebingen (Germany),L19IL2 - Ph I | L19IL2 at RD - Ph II | DTIC,Unknown status,Phase 1/Phase 2,96,Anticipated,FALSE
147,1249,NCT02710617,MH,HK,Ulm,Ulm,Ulm,3,10.1177/1932296818821105,https://journals.sagepub.com/doi/10.1177/1932296818821105,yes,14.12.2018,yes,"Unclear whether this is the right publication. Results are reported, but it is unclear whether the tests examined are the same. I tend to exclude this study.",,System Accuracy Evaluation of 2 CE-marked Blood Glucose Monitoring System,NA,2016-03-11,2016-03-31,NA,2016-05-31,Actual,NA,NA,Blood glucose monitoring systems for point-of-care-testing,Completed,N/A,109,Actual,FALSE
154,1271,NCT03423576,MH,HK,Ulm Würzburg,Ulm Würzburg,Ulm Würzburg Frankfurt Hannover,3,,https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/5_Publikationen/Gesundheit/Berichte/Abschlussbericht_VEMSE-190416.pdf,yes,01.12.2018,no,,,Effects of a Comprehensive Patient-centered Health Service in Cystic Fibrosis (VEMSE-CF),Effects of a Comprehensive Patient-centered Health Service With a Focus on Psychosocial Services for Patients With Rare Diseases Using Cystic Fibrosis as an Example (Evaluation Eines Ganzheitlichen Patientenzentrierten Versorgungsmodells für Patienten Mit Seltenen Erkrankungen Unter Besonderer Berücksichtigung Der Psychosozialen Versorgung am Beispiel Mukoviszidose),2018-01-23,2011-08-01,Actual,2016-12-31,Actual,"Lutz Goldbeck, Prof. Dr.",Ulm University Hospital,comprehensive patient-centered outpatient health service with multiple components,Completed,N/A,318,Actual,FALSE
213,32,NCT01966146,HK,EN,Aachen,Aachen,,3,https://pubmed.ncbi.nlm.nih.gov/30004869/,10.1109/TBME.2018.2855661 ,yes,12.07.2018,no,,,Examination of Valve Insufficiency Before and After MitraClip or TAVI Procedure by 3D Echocardiography Compared to MRI,Quantitative Analysis of Catheter-based Interventional Therapies for Treating Valve Insufficiency by Using 3D Echocardiography.,2013-07-17,2013-05-31,NA,2014-10-31,Actual,NA,NA,Echography GE Healthcare Vivid E9,Completed,N/A,200,Anticipated,FALSE
222,45,NCT01644032,HK,EN,Aachen,Aachen,,3,https://pubmed.ncbi.nlm.nih.gov/30853880/,10.3389/fnins.2019.00042 ,yes,22.02.2019,no,,,Telemedically Supported Analgesia in the Emergency Medical Service,Telemedically Supported Analgesia in the Emergency Medical Service,2012-07-12,2012-08-31,NA,2015-09-30,Actual,"Rolf Rossaint, Prof. Dr.","University Hospital Aachen, Germany, Department of Anesthesiology",Teleconsultation,Completed,N/A,106,Actual,FALSE
228,61,NCT03105024,HK,EN,Bochum,Bochum,,3,https://pubmed.ncbi.nlm.nih.gov/31275188/, 10.3389/fpsyg.2019.01191 ,yes,18.06.2019,yes,"Participant characteristics do not seem to match exactly (registry entry mentions that participants should have a specific phobia [acrophobia], while the publication specifies ""healthy participants who had no current mental or neurological diseases"") ",,Self-efficacy Enhancement and Exposure Therapy,Enhancing Exposure: the Impact of Self-efficacy Enhancement on Treatment Outcome,2017-03-27,2017-03-22,Actual,2017-11-29,Actual,"Armin Zlomuzica, Dr.",Ruhr-University Bochum,Self-efficacy enhancement | Control intervention,Completed,N/A,71,Actual,FALSE
244,107,NCT00749723,HK,EN,Bonn Duisburg,Bonn Duisburg,,3,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977734/ ,10.1371/journal.pone.0227693,yes,23.01.2020,yes,Results from two HIT trials are reported and not sure whether any of the primary outcomes of interest are reported,,Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children,Therapy-Optimization Trial and Phase II Study for the Treatment of Relapsed or Refractory of Primitive Neuroectodermal Brain Tumors and Ependymomas in Children and Adolescents,2008-09-05,2006-02-01,NA,2016-01-31,Actual,"Gudrun Fleischhack, MD","Department of Pediatric Hematology & Oncology, Pediatrics III, University Children's Hospital Essen","carboplatin | etoposide | temozolomide | thiotepa, carboplatin, etoposide | temozolomide, thiotepa | autologous stem cell transplantation | intraventricular etoposide | trofosfamide, etoposide",Completed,Phase 2/Phase 3,174,Actual,FALSE
265,169,NCT02110043,HK,EN,Charite,Charite,,3,https://pubmed.ncbi.nlm.nih.gov/32280093/,10.3233/JAD-191234 ,yes,05.05.2020,yes,"""Data reported here were assessed during a randomized interventional trial comprising elderly subjects with MCI (registered at https://clinicaltrials.gov: NCT02110043, https://clinicaltrials.gov/show/NCT02110043). Data were compared with previously reported data of HE (NCT02110056, https://clinicaltrials.gov/show/NCT02110056 [21]), who underwent the identical study protocol. """,,Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by tDCS,Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by Transcranial Direct Current Stimulation - Proof of Principle and Mechanisms,2014-02-13,2014-03-31,NA,2017-10-31,Anticipated,"Agnes Flöel, Prof. Dr.","Charite University, Berlin, Germany",tDCS | training,Unknown status,N/A,21,Actual,FALSE
278,192,NCT01865604,HK,EN,Charite,Charite,,3,https://pubmed.ncbi.nlm.nih.gov/25576632/,10.1212/WNL.0000000000001230 ,yes,09.01.2015,yes,Total number of participants does not match exactly between registry entry and publication,,Impact of tDCS on Cerebral Autoregulation,NA,2012-12-18,2012-04-30,NA,2014-03-31,Actual,"Agnes Flöel, Prof. MD","Charite University, Berlin, Germany",Anodal tDCS | Cathodal tDCS | sham tDCS,Completed,N/A,60,Actual,FALSE
286,205,NCT01791790,HK,EN,Charite,Charite,,1,https://pubmed.ncbi.nlm.nih.gov/27247261/,10.1016/j.brs.2016.04.016 ,yes,28.04.2016,no,,,Effects of Brain Stimulation During Nocturnal Sleep on Memory Consolidation in Elderly Healthy Subjects,Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Nocturnal Slow Wave Sleep in Elderly Healthy Subjects,2013-02-13,2013-01-31,NA,2017-12-31,Anticipated,"Agnes Flöel, Professor",Charite Universitätsmedizin Berlin - Neurologie,Stimulation | SHAM,Unknown status,N/A,22,Anticipated,FALSE
288,218,NCT01532453,HK,EN,Charite,Charite,,1,,https://clinicaltrials.gov/ct2/show/NCT01532453?term=NCT01532453&draw=2&rank=1,no,08.01.2016,no,,Terminated but results posted on Ctgov,Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients,"Open, Multicentre, Randomised, Comparative, Prospective Trial With MD-3511356 Versus Standard Sun Protection Measures in Immunosuppressed Solid Organ Transplanted Patients for Prevention of UV-induced Carcinogenic Skin Alterations",2012-02-09,2010-11-30,NA,2014-01-31,Actual,"Claas Ulrich, MD","Klinikum der Charité Universitätsmedizin, Hauttumorzentrum Charité, D-10117 Berlin/Germany",MD-3511356 | Standard Sun Protection Measures,Terminated,Phase 3,244,Actual,TRUE
298,240,NCT01219244,HK,EN,Charite,Charite,,1,https://pubmed.ncbi.nlm.nih.gov/26433119/,10.1016/j.neuroimage.2015.09.050,yes,01.10.2015,no,,,Effects of Dietary Interventions on the Brain in Mild Cognitive Impairment (MCI),Enhancing Memory Functions in Patients With Mild Cognitive Impairment by Dietary Interventions and in Combination With Exercise and Cognitive Training - Proof of Concept and Mechanisms,2010-10-12,2010-08-31,NA,2016-12-31,Actual,"Agnes Floeel, Prof.",Charité University Berlin,caloric restriction | omega-3 supplementation | resveratrol supplementation | Placebo | 2nd step: intervention + physical / cognitive training | 2nd step: intervention + control,Completed,Phase 2/Phase 3,330,Anticipated,FALSE
301,247,NCT01105143,HK,EN,Charite,Charite,,2,https://pubmed.ncbi.nlm.nih.gov/32482712/,10.4049/jimmunol.2000108 ,yes,01.07.2020,no,,,Effects of Negative Energy Balance on Muscle Mass Regulation,Effects of Negative Energy Balance on Muscle Mass Regulation,2010-04-14,2012-03-31,Actual,2017-05-31,Actual,"Knut Mai, Prof",Charite,multimodal lifestyle intervention | placebo,Completed,N/A,81,Actual,FALSE
305,255,NCT00850629,HK,EN,Charite,Charite,,1,https://pubmed.ncbi.nlm.nih.gov/27298729/,10.1186/s40608-016-0110-8,yes,10.06.2016,no,,,Hormonal Regulation of Body Weight Maintenance,Hormonal Regulation of Body Weight Maintenance,2009-02-17,2010-01-31,Actual,2016-01-31,Actual,"Knut Mai, Prof",Charite,multimodal lifestyle intervention | placebo,Completed,N/A,286,Actual,FALSE
307,261,NCT00437307,HK,EN,Charite,Charite,,3,https://pubmed.ncbi.nlm.nih.gov/27789470/,10.1093/annonc/mdw418,yes,26.10.2015,yes,"Please note: NCT ID mentioned in the full-text publication was mixed up, i.e. it is wrong and describes the registry entry of a different trial (different N, comparison, and outcomes)",,Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse,"Topotecan Plus Carboplatin im Vergleich Zur Standardtherapie (Paclitaxel Plus Carboplatin Oder Gemcitabin Plus Carboplatin) in Der Therapie Von Patientinnen Mit Platin-sensitivem Rezidivierten Epithelialen Ovarialkarzinom, Peritonealkarzinom Oder Tubenkarzinom",2007-02-19,2007-03-31,NA,2015-06-30,Actual,Jalid Sehouli,Charité Campus Vichow Klinikum,Topotecan,Completed,Phase 3,550,Actual,FALSE
1131,297,NCT02847260,HK,EN,Dresden Duisburg Hamburg Heidelberg Köln Leipzig Munich Regensburg Homburg Würzburg,Dresden Duisburg Hamburg Heidelberg Köln Leipzig LMU Regensburg Homburg Würzburg,,1,,https://clinicaltrials.gov/ct2/show/results/NCT02847260?term=NCT02847260&draw=1&rank=1,no,08.09.2017,no,,Trial results posted on CTgov,Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID),"A 16 Week, Open Label, Multi-centre, Study to Evaluate the Safety, Tolerability and Pharmacodynamic Effects of a Rapid Dose Titration Regimen of Subcutaneous Remodulin® Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)",2016-07-25,2012-04-30,NA,2014-03-31,Actual,Grünig,"Thoraxklinik am Universitätsklinikum, Heidelberg, Germany",Remodulin,Completed,Phase 4,39,Actual,TRUE
327,304,NCT02721836,HK,EN,Duisburg,Duisburg,,2,https://pubmed.ncbi.nlm.nih.gov/29076171/,10.1111/apt.14400 ,yes,27.10.2017,no,,,Yoga for Patients With Irritable Bowel Syndrome,Randomized Controlled Trial on Yoga for Irritable Bowel Syndrome,2016-03-17,2016-04-30,NA,2017-05-31,Actual,NA,NA,Yoga | Nutrition Counselling,Completed,N/A,59,Actual,FALSE
380,440,NCT01515852,TB,EN,Frankfurt,Frankfurt,,3,https://pubmed.ncbi.nlm.nih.gov/27671885/,10.1016/j.wneu.2016.09.064,yes,23.09.2016,no,,,General Anesthesia vs. Local Anesthesia in Stereotaxy,General Anesthesia vs. Local Anesthesia in Stereotaxy,2012-01-23,2012-01-31,NA,2014-01-31,Anticipated,NA,NA,general anesthesia in stereotactic biopsy | local anesthesia in stereotactic biopsy,Unknown status,N/A,80,Anticipated,FALSE
818,560,NCT02403986,TB,EN,Hamburg,Hamburg,,1,,https://clinicaltrials.gov/ct2/show/NCT02403986?term=NCT02403986&draw=2&rank=1,no,06.09.2019,no,,Trial results posted on CTgov,An Efficacy and Safety Study Evaluating Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face,"A Randomised, Multi-centre, Parallel-group, Efficacy and Safety Study Evaluating Two and Three Initial Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face",2015-03-26,2015-04-30,NA,2017-03-30,Actual,"Martina Kerscher, MD",University of Hamburg,Restylane Vital Skinboosters Lidocaine,Completed,Phase 4,53,Actual,TRUE
35,885,NCT02372318,SW,EN,Mannheim,Mannheim,,3,https://pubmed.ncbi.nlm.nih.gov/31740271/,10.1016/j.euroneuro.2019.10.014,yes,15.11.2019,no,,,Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity,Nalmefene Challenge to Modulate Neural Reactivity to Alcohol-related and Emotional Cues in Non-treatment Seeking Alcohol Dependent Participants,2015-02-06,2015-04-30,NA,2016-05-31,Actual,"Sabine Vollstädt-Klein, Prof. Dr.","Central Institute of Mental Health, Mannheim",Nalmefene | Placebo,Terminated,Early Phase 1,23,Actual,FALSE
60,1084,NCT02021942,SW,EN,Regensburg,Regensburg,,1,,https://clinicaltrials.gov/ct2/show/NCT02021942?term=NCT02021942&draw=2&rank=1,no,05.02.2018,no,,Trial results posted on CTgov,Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size,Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size,2013-12-20,2012-03-31,NA,2015-10-31,Actual,NA,NA,SOM230 LAR,Completed,Phase 2,16,Actual,TRUE
135,1212,NCT01914341,MH,EN,Tübingen,Tübingen,,2,,http://dx.doi.org/10.15496/publikation-9460,no,01.01.2016,no,,Dissertation: (Früh-) Start mit Musik? - Kurzzeitige Effekte pentatonischer Livemusik auf physiologische Parameter Früh- und Reifgeborener und auf die Ängstlichkeit ihrer Mütter,Short Term Effects of Live Music in Newborn Infants,Short-term Effects of Live Pentatonic Music on Physiological Parameters in Newborns Infants,2013-07-29,2013-07-31,NA,2014-01-31,Actual,"Jan Vagedes, Dr.",ARCIM-Institute; University Hospital Tuebingen,Music,Completed,N/A,20,Actual,FALSE
193,6,NCT02836665,HK,TB,Aachen,Aachen,,3,10.1007/s11739-020-02323-1,https://link.springer.com/article/10.1007/s11739-020-02323-1,yes,04.04.2020,no,,,Application of Telemedicine for Dermatological Emergency Patients,Application of Telemedicine for Dermatological Emergency Patients,2016-07-12,2016-08-31,Actual,2017-12-31,Actual,"Luigi Villa, Dr. med.",RWTH Aachen University,Telemedicine for dermatological emergency patients,Completed,N/A,100,Actual,FALSE
201,16,NCT02395159,HK,TB,Aachen,Aachen,,3,10.1016/j.ejvs.2018.05.018,https://www.sciencedirect.com/science/article/pii/S1078588418303137,yes,30.06.2018,no,,,Reduction of Groin Wound Infections After Vascular Surgery by Using an Incision Management System (IMS),Reduction of Groin Wound Infections After Vascular Surgery in Patients With Risk Factors by the Use a Negative Pressure Wound Incision Management System (KCI Prevena),2015-03-16,2015-07-31,Actual,2017-10-10,Actual,Jochen Grommes,"University Hospital, Aachen",Prevena™ IMS | sterile plaster dressings,Completed,N/A,204,Actual,FALSE
206,24,NCT02129400,HK,TB,Aachen,Aachen,,3,10.1007/s40279-016-0505-1,https://pubmed.ncbi.nlm.nih.gov/26939898/,yes,01.11.2016,no,,Abstract states NCT number but article did not appear in Google search for NCT number,Influence on Erythropoetin-level by Xenon,Xenon-inhalation: Elimination of Xenon and Its Effect on Erythropoetin Levels in Blood of Healthy Volunteers,2014-04-15,2014-05-31,NA,2015-01-31,Actual,"Rolf Rossaint, Prof. M.D.","University Hospital RWTH Aachen, Department for Anesthesia",Xenon pro Anaesthesia 100 % (V/V) | Aer medicinalis Linde 100%,Terminated,Phase 3,36,Actual,FALSE
215,34,NCT01934699,HK,TB,Aachen,Aachen,,2,10.1007/s00392-017-1099-9,https://link.springer.com/article/10.1007/s00392-017-1099-9?shared-article-renderer,yes,20.03.2017,no,,,Intraprocedural Determination of Myocardial Vitality Using 2 Different Imaging Methods,Intraprocedural Determination of Myocardial Vitality Using Speckle Tracking Echocardiography Compared to Two-time MRI Diagnostics,2013-08-29,2011-06-30,NA,2016-07-31,Anticipated,"Michael Becker, MD","University Hospital, Aachen",Cardiac ultrasound | MRI scanner,Unknown status,N/A,130,Actual,FALSE
1243,57,NCT01812616,HK,TB,Aachen Düsseldorf Erlangen,Aachen Düsseldorf Erlangen,,3,10.1200/JCO.2017.35.15_suppl.2046,https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2046 ,yes,30.05.2017,yes,Seems to report results but states different NCT number; Alternative publication here https://www.gwpharm.co.uk/about/news/gw-pharmaceuticals-achieves-positive-results-phase-2-proof-concept-study-glioma ,,A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients,"A Two Part Study to Assess the Tolerability, Safety and Pharmacodynamics of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma",2013-03-14,2014-09-30,NA,2016-06-30,Actual,"Michael Sabel, MD",Zentrum für Neuroonkologie der Universität Duesseldorf,Sativex | Placebo,Completed,Phase 1/Phase 2,21,Actual,FALSE
234,76,NCT01854255,HK,TB,Bochum,Bochum,,2,10.1200/JCO.2017.35.4_suppl.99,https://ascopubs.org/doi/10.1200/JCO.2017.35.4_suppl.99 ,yes,21.03.2017,no,,Short abstract but with data table,Intraperitoneal Aerosol Chemotherapy in Gastric Cancer,"Feasibility, Efficacy and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Cisplatin and Doxorubicin in Patients With Gastric Cancer and Peritoneal Carcinomatosis: an Open-label, Single-arm, Phase II Clinical Trial",2013-05-12,2013-11-30,NA,2016-11-30,Actual,"Marc A Reymond, MD",Ruhr University of Bochum,doxorubicin and cisplatin,Completed,Phase 2,35,Actual,FALSE
1252,128,NCT02793557,HK,TB,Charite,Charite,,8,,https://www.americanhairresearchsociety.org/wp-content/uploads/2019/05/Final-Program_WCHR2019_04-11-19.pdf,no,,yes,,1 poster presents outcomes of 2 studies,Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth,"A Randomised, Double-blind, Placebo-controlled Trial of FOL-005 to Investigate Clinical Safety and Effect on Hair Growth in Healthy Volunteers",2016-05-16,2016-01-31,NA,2017-03-31,Actual,"Ulrike Blume-Peytavi, Professor","Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin Berlin Charitéplatz 1 - 10117 Berlin",Placebo | FOL-005,Completed,Phase 1/Phase 2,44,Actual,FALSE
268,174,NCT02071615,HK,TB,Charite,Charite,,3,10.1007/s00213-020-05691-w,https://link.springer.com/article/10.1007/s00213-020-05691-w ,yes,17.11.2020,no,,,"Effects of Modafinil, Caffeine and Methylphenidate in Healthy Volunteers","Effects of Modafinil, Caffeine and Methylphenidate on Functional Brain Activity and Cognitive Performance in Healthy Volunteers: a Randomized, Placebo-controlled, Double-blind fMRI Study",2014-02-15,2013-08-31,NA,2014-03-31,Actual,"Dimitris Repantis, MD","Department of Psychiatry and Psychotherapy, Charité - University",Methylphenidate 20 mg tablet given once by mouth | modafinil 200mg tablet given once by mouth | caffein 200mg tablet given once by mouth | placebo,Completed,N/A,48,Actual,FALSE
270,177,NCT02019134,HK,TB,Charite,Charite,,8,10.1177/2164956120912849,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290253/,no,10.06.2020,no,,Poster & abstract P05.67,Effectiveness of App-based Relaxation for Patients With Chronic Neck Pain,A Randomized Pragmatic Trial About the Effectiveness of an App Based Relaxation Technique for Patients With Chronic Neck Pain,2013-12-18,2014-03-31,Actual,2017-02-28,Actual,"Claudia M Witt, Prof. Dr. med","Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin",relaxation exercise | ususal care,Completed,N/A,220,Actual,FALSE
271,178,NCT01984788,HK,TB,Charite,Charite,,2,,https://www.jacionline.org/article/S0091-6749(16)30270-6/pdf,no,01.09.2016,no,,,Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE,A Phase 2a Double-Blind Placebo-Controlled 2-Period Crossover Study to Evaluate the Safety and Efficacy of BCX4161 as a Prophylactic Treatment to Reduce the Frequency of Attacks in Subjects With Hereditary Angioedema,2013-11-05,2013-11-30,NA,2014-05-31,Actual,"Marcus Maurer, MD","Charite University, Berlin, Germany",BCX4161 | Placebo,Completed,Phase 2,24,Actual,FALSE
273,181,NCT01963793,HK,TB,Charite,Charite,,3,10.2340/00015555-2780,https://pubmed.ncbi.nlm.nih.gov/28853492/ ,,12.01.2018,yes,Results first made public 2015 on EudraCT https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000410-38/results,Also check EudraCT Number 2013-000410-38,Topical Aprepitant in Prurigo Patients,Topical Aprepitant in Prurigo Patients An Exploratory Phase IIa Trial With Topically Applied Aprepitant in Patients With Prurigo,2013-09-18,2013-10-31,NA,2014-07-31,Actual,"Maurer (ICI) Marcus, Prof. Dr. med.","Allergie-Centrum-Charité, Charité Universitätsmedizin Berlin, Charitéplatz1, D-10117 Berlin",Aprepitant | Placebo,Completed,Phase 2,20,Actual,FALSE
274,188,NCT01914965,HK,TB,Charite,Charite Ulm Bochum Münster,University of Ulm Ruhr University of Bochum University Hospital Muenster,3,10.1371/journal.pone.0173872,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360242/,yes,21.03.2017,no,,,Apathy Cure Through Bupropion in Huntington's Disease,"A Randomized, Double-blind, Placebo-controlled Prospective Crossover Trial Investigating the Efficacy and Safety of the Treatment With Bupropion in Patients With Apathy in Huntington's Disease",2013-07-31,2012-06-30,NA,2014-05-31,Actual,"Josef Priller, MD","Charite University, Berlin, Germany",Bupropion | Placebo,Completed,Phase 2,40,Actual,FALSE
279,193,NCT01864707,HK,TB,Charite,Charite,,8,10.1186/s12906-017-1782-4,https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-017-1782-4,no,03.05.2017,no,,Abstract and poster,Acupuncture or MBSR for Patients With Fatigue and MS,Randomized Controlled Trial on the Efficacy of Acupuncture and the Efficacy of Mindfulness-Based Stress Reduction (MBSR) in Patients With Multiple Sclerosis Suffering From Fatigue,2013-04-02,2013-04-30,NA,2015-10-31,Actual,"Claudia M Witt, MD","Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin",Usual care + acupuncture | usual care+mbsr | usual care,Completed,N/A,104,Actual,FALSE
280,194,NCT01845142,HK,TB,Charite,Charite,,2,10.1371/journal.pone.0169620,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256876/,yes,23.01.2017,yes,,"1 study reports outcomes from 2 (complementary) trials, EudraCT Number: 2012-003217-33",Immunologic Action of a Single Dose Cholecalciferol,Immunologic Functions of a Single Dose of 100.000 I.U. Cholecalciferol (Vitamin D3),2013-04-24,2013-02-28,NA,2014-04-30,Actual,"Margitta Worm, Prof","Charite University, Berlin, Germany",single administration of 100.000 I.U. vitamin D | Placebo,Completed,Phase 4,40,Actual,FALSE
942,214,NCT01600573,HK,TB,Charite,Charite,,2,10.1200/JCO.2018.36.15_suppl.e17553,https://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e17553,yes,01.06.2018,no,,,Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ),A Phase I/II Study of Pazopanib and Weekly Topotecan in Patients With Platinum-resistant or Intermediate-sensitive Recurrent Ovarian Cancer,2012-05-09,2012-05-31,NA,2017-03-31,Anticipated,"jalid Sehouli, Prof. Dr.","Charite University, Berlin, Germany",pazopanib in combination with weekly topotecan,Unknown status,Phase 1/Phase 2,68,Anticipated,FALSE
705,221,NCT01503372,HK,TB,Charite,Charite,,8,10.1200/jco.2015.33.15_suppl.4033,https://ascopubs.org/doi/10.1200/jco.2015.33.15_suppl.4033,no,20.05.2015,no,,Abstract,FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer,"Pazopanib With 5-Fluorouracil, Leucovorin and Oxaliplatin (FLO) as 1st-line Treatment in Advanced Gastric Cancer; a Randomized Phase-II-study of the Arbeitsgemeinschaft Internistische Onkologie",2011-12-22,2011-11-30,NA,2017-12-14,Actual,"Peter Thuss-Patience, MD",Charite University medicine,"Pazopanib | 5-FU, Oxaliplatin, Leukovorin (FLO)",Completed,Phase 2,75,Actual,FALSE
297,239,NCT01221779,HK,TB,Charite,Charite,,3,10.1093/brain/aww002,https://pubmed.ncbi.nlm.nih.gov/26912641/,yes,16.02.2016,no,,,Chronic Aphasia - Improved by Intensive Training and Electrical Brain Stimulation,Chronic Aphasia - Improved by Intensive Training and Electrical Brain,2010-10-13,2011-01-31,NA,2014-12-31,Anticipated,"Marcus Meinzer, PhD","Charite, University Medicine, Neurology",Intensive language therapy | Intensive language therapy,Unknown status,Phase 2,40,Anticipated,FALSE
302,249,NCT01049100,HK,TB,Charite,Charite,,3,10.1016/j.ijrobp.2015.10.027,https://pubmed.ncbi.nlm.nih.gov/26853333/,yes,20.10.2015,yes,ly reports toxicity data (not a primary outcome),,Surgical Staging in Cervical Cancer Prior to Chemoradiation,"Prospective, Randomised and Multi-centric Therapy Optimisation Study for Examining the Influence of Surgical Staging on the Oncological Results for Patients With Cervix Carcinoma of the FIGO Stages IIB-IV After Chemoradiation",2010-01-13,2009-04-30,NA,2017-04-30,Anticipated,"Simone Marnitz, PD","Department of Radiooncology (Charité Campus Mitte und Virchow), Charitéplatz 1, 10117 Berlin, Germany",lymphadenectomy | Standard Staging,Unknown status,N/A,250,Anticipated,FALSE
309,264,NCT02227641,HK,TB,Charite Erlangen,Charite Erlangen,"Ludwig-Maximilians - University of Munich University of Regensburg Johannes Gutenberg University Mainz Charite University, Berlin, Germany University Hospital Augsburg",8,10.1182/blood.V128.22.2179.2179,https://ashpublications.org/blood/article/128/22/2179/100400/Adoptive-Transfer-of-CMV-and-EBV-Specific,yes,02.12.2016,no,Poster / abstract with very early results only,,Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation,"Prospective, Open, Randomized, Two-arm, Controlled, Multicenter Clinical Phase I/IIa Trial to Evaluate the Safety and Efficacy of Adoptive Immunotherapy With Allogeneic CMV/EBV Specific, Peptide Stimulated T-cells (CD3+) for Prevention or Preemptive Therapy of Reactivation of CMV and/or EBV in Patients After Allogeneic, HLA Identical Stem Cell Transplantation",2014-08-26,2014-10-31,NA,2017-03-31,Anticipated,"Armin H Gerbitz, MD, PhD","Charite University, Berlin, Germany",CMV/EBV specific T-cell,Unknown status,Phase 1/Phase 2,50,Anticipated,FALSE
316,285,NCT02045550,HK,TB,Dresden,Dresden,,8,10.1186/s12906-017-1783-3,https://link.springer.com/article/10.1186/s12906-017-1783-3,no,03.05.2017,no,Poster / abstract P138,,Tolerance and Effect of a Prophylactical Treatment With Ivy Leaves Dry Extract in Recurrent Wheezy Bronchitis,Tolerance and Effect of a Prophylactical Treatment With a Cough Medicine Con-taining Ivy Leaves Dry Extract in Children With Recurrent Wheezy Bronchitis,2014-01-13,2014-01-31,NA,2015-08-31,Anticipated,"Christian Vogelberg, MD PhD",Technische Universität Dresden,Prospan Syrup,Unknown status,Phase 2,60,Anticipated,FALSE
333,313,NCT02404844,HK,TB,Duisburg,Duisburg,,3,10.1002/cam4.3092,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333856/,yes,30.04.2020,,,Results posted on EudraCT earlier : 28 Oct 2018 https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000599-24/results ,"Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer","Molecularly Stratified Parallel Cohort, Single Arm Phase II Trial of the Phosphoinositide 3-kinase (PI3K) Inhibitor Buparlisib (BKM120) in Combination With Tamoxifen in Patients With Hormone Receptor-positive, HER2-negative Inoperable (Locally Advanced or Metastatic) Breast Cancer With Prior Exposure to Antihormonal Therapy",2015-02-20,2014-12-31,NA,2017-10-19,Actual,"Anja Welt, MD","University Hospital, Essen",BKM120 | Tamoxifen,Completed,Phase 2,48,Actual,FALSE
335,318,NCT02099968,HK,TB,Duisburg,Duisburg,several unis,2,10.1101/2020.02.23.20027029,https://www.medrxiv.org/content/10.1101/2020.02.23.20027029v1,no?,25.02.2020,no,,Preprint,Comprehensive Lifestyle Modification for Patients With Hypertension and Metabolic Syndrome: a Multicenter Randomized Controlled Trial,Intensivierte Ernährungs- Und Lebensstilmodifikation Bei Patienten Mit Bluthochdruck Und Kardiometabolischer Risikokonstellation. Eine Zweizentrische Randomisiert-kontrollierte Interventionsstudie über 6 Monate,2014-03-26,2014-04-30,NA,2015-12-31,Actual,NA,NA,Comprehensive Lifestyle Modification | Standard Lifestyle Modification / modified DASH,Completed,N/A,145,Actual,FALSE
338,329,NCT01377025,HK,TB,Duisburg,Duisburg,,8,10.1200/JCO.2017.35.15_suppl.9511,https://ascopubs.org/doi/10.1200/JCO.2017.35.15_suppl.9511,no,30.05.2017,no,Abstract,,A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma,"A Randomized Discontinuation, Blinded, Placebo-Controlled Phase II Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma",2011-06-14,2011-06-30,NA,2017-06-30,Anticipated,"Max E. Scheulen, Prof.",Universiätsklinikum Essen,Placebo | Sorafenib | Sorafenib,Unknown status,Phase 2,200,Anticipated,FALSE
346,363,NCT01455675,HK,TB,Düsseldorf,Düsseldorf,,2,,https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000801-39/results,no,12.04.2019,no,EudraCT results,EudraCT Number: 2011-000801-39,Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients,Phase III Study to Evaluate Clinical Efficacy and Safety of Avian Polyclonal Anti-Pseudomonas Antibodies (IgY) in Prevention of Recurrence of Pseudomonas Aeruginosa Infection in Cystic Fibrosis Patients,2011-10-18,2011-10-31,NA,2017-06-27,Actual,"Antje Schuster, Prof. Dr.",Universitätsklinikum Düsseldorf,IgY | Placebo,Completed,Phase 3,164,Actual,FALSE
91,668,NCT02135926,EN,TB,Heidelberg,Heidelberg,,3,10.1007/s00062-016-0538-8,https://link.springer.com/article/10.1007/s00062-016-0538-8,yes,05.09.2016,no,,,Thrombectomy in Patients Ineligible for iv tPA,Comparison of Thrombectomy and Standard Care for Ischemic Stroke in Patients Ineligibility for Tissue Plasminogen Activator Treatment,2014-04-30,2014-03-31,NA,2017-02-01,Actual,"Martin Bendszus, MD",University Hospital Heidelberg,Thrombectomy | Best medical care,Terminated,N/A,4,Actual,FALSE
4,754,NCT02144870,SW,TB,Köln,Köln,,3,10.1177/0145445518796203,https://journals.sagepub.com/doi/10.1177/0145445518796203,yes,27.08.2018,no,,,Efficacy of Psychotherapy Treatment of Children With Tics,Randomized Control Trial on the Efficacy of Habit Reversal Treatment Programme in Children and Adolescents - a Comparison With Resource Activation Treatment,2014-04-14,2013-11-30,NA,2017-09-30,Anticipated,NA,NA,Habit Reversal Training | Resources activation,Unknown status,N/A,100,Anticipated,FALSE
5,756,NCT02116088,SW,TB,Köln,Köln,,3,10.1177/0143034320958743,https://journals.sagepub.com/doi/10.1177/0143034320958743,yes,21.09.2020,yes,Could be different study,,Prevention and Intervention of Externalizing Problem Behavior in School: Development and Evaluation of a Teacher Coaching.,Prevention and Intervention of Externalizing Problem Behavior in School: Development and Evaluation of a Teacher Coaching.,2014-04-14,2012-10-31,NA,2017-04-30,Anticipated,"Manfred Döpfner, Univ. Prof. Dr.",University Clinic of Cologne,Teacher Coaching,Unknown status,N/A,53,Anticipated,FALSE
33,882,NCT02487381,SW,TB,Mannheim,Mannheim,,2,10.3389/fpsyt.2020.576877,https://www.frontiersin.org/articles/10.3389/fpsyt.2020.576877/full,yes,13.11.2020,no,,,Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids,"Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids on the Endocannabinoid System, Cognition and Neuronal Oscillations",2015-06-29,2015-04-30,NA,2015-08-31,Actual,NA,NA,delta-9-tetrahydrocannabinol | Cannabidiol | Placebo,Completed,Phase 1,60,Anticipated,FALSE
44,904,NCT03046940,SW,TB,Marburg,Marburg,,3,10.13140/RG.2.2.19672.85765,https://www.researchgate.net/publication/337734613_Patient-centered_communication_results_in_better_medication_adherence_A_randomized_controlled_trial,no,14.11.2018,yes,,,The Influence of Doctor-patient Communication on Patients' Willingness to Take Medication,The Influence of Doctor-patient Communication on Patients' Willingness to Take Medication,2017-01-30,2017-03-15,Actual,2017-06-08,Actual,"Winfried Rief, PhD, Prof",Philipps University Marburg Medical Center,Doctor-centered style of communication | Patient-centered style of communication,Completed,N/A,120,Actual,FALSE
158,926,NCT03092206,NR,TB,Munich,TU,,3,10.3851/IMP3271,https://www.intmedpress.com/journals/avt/abstract.cfm?id=3271&pid=48 ,no?,03.10.2018,no,,"""Short communication""",Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral Medication,Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral Medication: The TAF-IR Study,2017-03-21,2017-04-18,Actual,2017-07-28,Actual,NA,NA,F/TAF | E/C/F/TAF | R/F/TAF,Completed,Phase 1,30,Actual,FALSE
110,1098,NCT02318810,MH,TB,Rostock,Rostock,,3,10.1111/anae.14035,https://pubmed.ncbi.nlm.nih.gov/28913862/,yes,14.09.2017,no,,,Influence of the Neuromuscular Blockade on Mask Ventilation,"The Influence of the Neuromuscular Blockade on Mask Ventilation; a Placebo Controlled, Randomized Trial With Three Different Dosages of Rocuronium (0.3 mg/kg, 0.6 mg/kg and 0.9 mg/kg)",2014-12-12,2015-03-31,NA,2016-05-31,Actual,"Thomas Mencke, Prof.",University of Rostock,Rocuronium 0.3 mg/kg | Rocuronium 0.6 mg/kg | Rocuronium 0.9 mg/kg | Placebo,Completed,N/A,300,Actual,FALSE
64,1111,NCT03184272,SW,TB,Schleswig-Holstein,Schleswig-Holstein,,1,10.1186/s12871-020-01110-x,https://pubmed.ncbi.nlm.nih.gov/32778047/,yes,10.08.2020,no,,,Non-invasive Assessment of Cardiac Output and Fluid Responsiveness in Bariatric Surgery,Accuracy of Non-invasive Assessment of Cardiac Output and Fluid Responsiveness in Patients Undergoing Bariatric Procedures.,2017-06-03,2015-06-01,Actual,2017-06-01,Actual,NA,NA,baseline alert 1 | Anti-Trendelenburg-position (ATB) | ATB in narcosis | baseline in narcosis 1 | passive leg raising | volume bolus substitution | baseline in narcosis 2 | start capnoperitoneum | ATB plus capnoperitoneum | ATB plus capnoperitoneum plus volume bolus substitution | ATB loss of capnoperitoneum | baseline | baseline alert 2 | torso position rising 30° at the beginning | torso position rising 30° at the end,Completed,N/A,50,Actual,FALSE
122,1176,NCT02858817,MH,TB,Tübingen,Tübingen,,3,10.1038/nature21060,https://pubmed.ncbi.nlm.nih.gov/28199305/,yes,15.02.2017,no,,Malaria vaccine challenge trial,Safety and Protective Efficacy of IV Immunization With Cryopreserved PfSPZ Under A/P Chemoprophylaxis,Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Atovaquone/Proguanil Chemoprophylaxis,2016-07-28,2016-11-28,Actual,2017-11-16,Actual,"Peter G Kremsner, Prof","University Hospital Tübingen, Tübingen, Germany","atovaquone/proguanil 250mg/100mg (A/P) | PfSPZ Challenge (NF54) | NaCl 0,9%",Completed,Phase 1,30,Actual,FALSE
136,1218,NCT01817738,MH,TB,Tübingen,Tübingen,,2,,https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006314-14/results,no,01.02.2018,no,,prelimiary here https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288759/ full results here https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006314-14/results,Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer,"A Randomised, Double-blind, Placebo-controlled, Phase I/II Trial of RNActive®-Derived Cancer Vaccine (CV9104) in Asymptomatic or Minimally Symptomatic Patients With Metastatic Castrate-refractory Prostate Cancer",2013-02-08,2012-08-31,NA,2017-01-31,Actual,"Arnulf Stenzl, Prof. Dr.",University Hospital of Tübingen; Dept. of Urology,CV9104 | Placebo,Terminated,Phase 1/Phase 2,197,Actual,FALSE
148,1251,NCT02531386,MH,TB,Ulm,Ulm,,2,10.1089/dia.2016.0408,https://www.liebertpub.com/doi/10.1089/dia.2016.0408,yes,01.10.2017,no,,,System Accuracy Evaluation of 6 CE-marked Blood Glucose Monitoring System Following ISO 15197:2013,"System Accuracy Evaluation of Accu-Chek Aviva Nano (Roche Diagnostics), Accu-Chek Performa Nano (Roche Diagnostics), FreeStyle Lite (Abbott Diabetes Care), OneTouch Verio IQ (LifeScan), Contour Next Link 2.4 (Bayer Consumer Care), One Additional CE-marked Blood Glucose Monitoring System Following ISO 15197:2013",2015-08-07,2015-08-31,NA,2015-11-30,Actual,NA,NA,6 blood glucose monitoring systems for self-testing (blood glucose meters),Completed,N/A,120,Anticipated,FALSE
351,1280,NCT02694926,HK,TB,Würzburg,Würzburg,numerous unis,2,10.1530/EJE-20-0181,https://eje.bioscientifica.com/view/journals/eje/183/2/EJE-20-0181.xml,yes,01.08.2020,no,,,National Education Programme for Patients With Chronic Adrenal Insufficiency,National (German-wide) Education Programme for Patients With Chronic Adrenal Insufficiency,2016-02-08,2014-12-31,NA,2017-12-31,Actual,"Stefanie Hahner, MD, Prof.",University Hospital Wuerzburg,Education,Completed,N/A,528,Actual,FALSE
194,7,NCT02790073,HK,MH,Aachen,Aachen,Aachen (PI) / Sanifit Therapeutics S. A. (Sponsor),3,10.1007/s40620-019-00631-0,https://link.springer.com/article/10.1007%2Fs40620-019-00631-0,yes,10.08.2019,no,,,Phase 2 Study With SNF472 in Calciphylaxis Patients,Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients,2016-05-25,2016-05-31,Actual,2017-11-15,Actual,Vincent Brandenburg,RWTH Aachen University,SNF472,Completed,Phase 2,14,Actual,TRUE
210,29,NCT02002871,HK,MH,Aachen,Aachen,Aachen (PI) / Philips Electronics Nederland BV (Sponsor),3,10.1159/000448000,https://www.karger.com/Article/FullText/448000,yes,19.08.2016,no,,,Blue Light for Treating Eczema,"Monocenter, Randomized, Intraindividual, Open Label, Exploratory Study Comparing 4 Weeks of Treatment With 453nm Blue Light With no Treatment in Patients With Eczema",2013-12-02,2013-10-31,NA,2014-03-31,Actual,"Verena von Felbert, PD Dr.","Klinik for Dermatology and Allergy, medical faculty of the RWTH Aachen",PSO-CT02 device,Completed,N/A,21,Actual,TRUE
1258,231,NCT01347567,HK,MH,Charite,Charite,Charite (PI) / Alere San Diego (Sponsor),3,10.1002/ejhf.1053,https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.1053,yes,04.01.2018,yes,"recruitment of the trial was terminated early, so the arms were pooled and analysed as a single observational study (would this count as a trial publication?)","one PI affiliated to 'Klinikum Ernst von Bergmann, Akademisches Lehrankenhaus der Charite Universitätsmedizin Berlin' (does that count for a German UMC?)",Heart Failure (HF) Outpatient Monitoring Evaluation (HOME) Study,HF Outpatient Monitoring Evaluation (HOME) Study,2011-05-03,2011-04-30,NA,2014-01-31,Actual,"Franz Kleber, Professor","Klinikum Ernst von Bergmann, Akademisches Lehrankenhaus der Charite Universitätsmedizin Berlin, Germany",Interventions with heart failure medications,Completed,N/A,145,Actual,FALSE
323,298,NCT02547519,HK,MH,Dresden Munich,Dresden TU,Dresden Munich TU,3,10.1101/2020.06.12.20129189,https://www.medrxiv.org/content/10.1101/2020.06.12.20129189v3,yes,21.07.2020,yes,preprint - does it count?,,Pre-POINT-Early Study,Pilot Study Using Oral Insulin at Early Age for Immune Efficacy in Primary Prevention of Type 1 Diabetes,2015-08-29,2015-08-31,NA,2017-12-31,Actual,"Anette-G. Ziegler, Prof. Dr., MD","Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Lehrstuhl für Diabetes und Gestationsdiabetes, der Technischen Universität München",Oral Insulin | Placebo,Completed,Phase 2,44,Actual,FALSE
388,463,NCT02610764,TB,MH,Freiburg,Freiburg,Freiburg,3,10.3390/cancers11030397,https://www.mdpi.com/2072-6694/11/3/397/htm,yes,21.03.2019,yes,"no registry number provided, so I had to decide based on the study design",,Pilot Sudy: Resectable Esophageal Adenocarcinoma and the Relevance of CTC,Resectable Esophageal Adenocarcinoma: The Influence of Multimodal Therapy on the Prevalence and Enumeration of Circulating Tumor Cells in Comparison With Conventional Response Evaluation in a Feasibility Study,2015-11-15,2015-11-30,NA,2016-12-31,Actual,"Birte Kulemann, Dr. med.",University Hospital Freiburg,Blood Test for CTC evaluation,Completed,N/A,19,Actual,FALSE
